Evofem Biosciences, Inc. provided sales guidance for the third quarter of 2023. For the expects sales to be $5.0 million to $5.2 million for the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 USD | 0.00% |
|
+4.84% | -79.69% |
May. 16 | Transcript : Evofem Biosciences, Inc. - Special Call | |
May. 15 | Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-79.69% | 1.03M | |
+41.68% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.96% | 246B | |
+0.33% | 225B | |
+10.66% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023